We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL36 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1338.2
Number of samples
349
Samples
Sample
Description
TPM
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
5265.0
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
5073.9
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
4261.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
4091.1
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
3929.9
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
3772.0
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
3768.3
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
3740.2
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
3698.0
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
3615.4
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
3534.0
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
3327.2
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
3306.2
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
3106.3
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
3080.6
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
3040.5
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
3037.9
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
2946.3
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
2902.0
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
2883.0
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
2746.9
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
2738.3
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
2736.3
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
2721.8
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
2719.5
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
2676.8
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
2673.5
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
2672.5
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
2575.4
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
2571.4
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
2452.7
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
2423.3
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
2417.7
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
2409.6
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
2405.8
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
2382.0
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
2325.2
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
2324.7
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
2278.6
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
2246.2
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
2213.9
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
2197.7
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
2180.1
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
2126.7
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
2094.4
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
2089.8
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
2069.2
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
2038.3
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
2017.1
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
2001.6
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
1990.0
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
1973.0
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
1971.6
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
1954.6
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
1952.4
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
1946.1
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
1933.8
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
1930.3
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
1926.6
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
1921.5
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
1919.1
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
1907.2
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
1873.4
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
1866.9
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
1853.0
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
1840.6
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
1829.7
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
1821.6
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
1800.8
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
1798.2
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
1788.9
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
1787.9
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
1774.6
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
1770.4
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
1763.7
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
1753.9
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
1746.8
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
1731.7
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
1707.0
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
1669.4
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
1659.8
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
1651.2
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
1646.9
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
1631.4
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
1623.4
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
1616.6
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
1615.6
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
1608.5
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
1606.5
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
1601.3
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
1596.8
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
1596.5
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
1594.3
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
1592.6
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
1567.8
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
1565.7
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
1565.3
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
1553.7
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
1550.5
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
1549.6
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1547.5
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1544.2
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
1538.7
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
1538.6
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
1524.2
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
1505.6
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
1495.9
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
1489.4
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
1482.8
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
1471.1
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
1461.1
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
1459.2
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
1456.5
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
1427.1
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
1414.9
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
1409.9
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
1406.0
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1400.4
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
1400.1
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
1394.6
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
1393.2
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
1388.5
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
1377.3
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
1377.1
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
1374.1
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
1369.8
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
1363.5
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
1353.1
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
1351.9
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
1342.6
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
1334.4
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
1331.2
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
1327.3
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
1321.9
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
1317.4
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1304.2
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
1301.0
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
1300.3
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
1298.8
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
1298.0
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
1274.0
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
1266.9
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
1257.8
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
1257.4
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
1254.6
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1252.3
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
1251.3
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
1246.3
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
1244.0
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
1226.6
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
1218.8
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
1218.0
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
1217.9
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
1206.9
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1204.7
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
1201.2
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
1198.0
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
1196.6
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
1188.3
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
1186.4
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
1183.6
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
1171.5
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
1170.6
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
1170.0
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
1166.6
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
1163.8
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
1162.6
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
1148.4
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
1146.4
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1136.2
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
1133.3
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
1133.1
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
1131.3
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
1131.2
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
1129.5
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
1125.8
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
1122.1
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
1119.1
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1118.5
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
1115.7
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
1109.5
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1106.2
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
1099.0
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
1096.2
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
1095.5
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
1087.5
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
1084.5
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
1081.4
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
1076.5
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
1075.2
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
1073.4
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
1067.9
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
1067.3
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
1064.1
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1063.6
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
1059.8
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1048.5
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
1045.5
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
1036.7
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
1027.8
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
1025.2
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
1013.2
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
1011.0
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
1005.2
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
1001.1
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
984.1
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
982.1
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
981.4
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
979.5
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
975.3
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
974.5
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
968.7
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
967.8
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
967.2
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
958.2
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
957.5
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
952.1
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
950.9
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
939.0
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
931.8
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
930.1
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
929.2
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
928.9
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
921.5
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
920.2
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
913.6
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
912.9
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
911.3
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
910.2
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
909.8
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
907.7
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
903.3
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
899.5
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
898.7
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
898.3
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
892.1
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
890.7
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
887.7
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
874.6
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
872.6
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
866.0
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
863.5
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
860.6
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
859.2
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
850.3
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
848.4
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
845.4
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
841.3
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
840.8
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
835.7
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
834.1
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
832.1
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
828.3
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
825.0
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
824.0
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
821.1
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
818.5
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
813.1
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
807.1
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
806.9
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
798.9
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
797.3
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
795.8
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
791.1
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
790.5
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
781.4
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
778.7
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
770.5
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
762.4
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
754.7
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
752.1
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
749.6
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
748.6
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
748.6
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
747.3
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
746.6
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
741.4
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
740.7
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
728.0
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
725.4
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
720.7
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
713.6
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
712.8
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
711.4
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
710.7
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
710.4
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
706.0
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
704.2
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
701.3
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
701.1
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
696.9
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
693.2
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
692.0
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
688.1
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
682.2
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
678.0
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
671.0
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
668.0
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
667.3
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
666.1
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
665.8
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
657.4
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
654.8
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
652.5
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
650.5
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
650.0
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
636.5
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
631.3
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
629.1
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
628.6
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
628.1
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
622.5
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
614.9
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
612.5
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
611.8
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
610.0
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
599.4
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
597.3
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
596.4
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
596.3
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
587.6
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
580.6
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
578.8
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
576.2
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
573.4
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
571.1
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
571.0
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
559.9
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
545.8
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
542.3
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
514.1
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
514.1
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
503.9
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
500.3
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
498.4
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
497.7
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
496.1
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
492.8
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
476.3
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
475.9
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
474.7
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
454.1
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
441.9
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
432.9
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
431.3
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
429.7
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
419.5
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
378.4
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL36 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1207.5
Number of samples
81
Samples
Sample
Description
TPM
DO46611
0 years, female, NA, stage:III, dead, 734 days
8023.7
DO46576
0 years, female, NA, stage:III, alive, 133 days
5934.2
DO46356
0 years, female, NA, stage:III, dead, 911 days
4777.1
DO46366
0 years, female, NA, stage:III, dead, 2054 days
4346.9
DO46333
0 years, female, NA, stage:III, dead, 359 days
3399.4
DO46384
0 years, female, NA, stage:III, dead, 614 days
3081.9
DO46402
0 years, female, NA, stage:III, dead, 511 days
2813.1
DO46568
0 years, female, NA, stage:III, dead, 320 days
2618.6
DO46390
0 years, female, NA, stage:III, dead, 374 days
2321.6
DO46342
0 years, female, NA, stage:III, dead, 1398 days
2095.8
DO46331
0 years, female, NA, stage:III, dead, 612 days
1928.3
DO46453
0 years, female, NA, stage:III, dead, 3294 days
1739.6
DO46591
0 years, female, NA, stage:III, dead, 195 days
1715.9
DO46546
0 years, female, NA, stage:III, dead, 1889 days
1626.0
DO46364
0 years, female, NA, stage:III, dead, 806 days
1422.8
DO46443
0 years, female, NA, stage:III, dead, 2464 days
1420.1
DO46370
0 years, female, NA, stage:III, dead, 1727 days
1333.0
DO46380
0 years, female, NA, stage:III, dead, 1423 days
1246.3
DO46412
0 years, female, NA, stage:III, dead, 597 days
1111.5
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
1110.6
DO46326
0 years, female, NA, stage:III, dead, 701 days
1105.2
DO46432
0 years, female, NA, stage:III, alive, 2218 days
1070.5
DO46350
0 years, female, NA, stage:III, dead, 886 days
1059.4
DO46602
0 years, female, NA, stage:III, dead, 205 days
1021.3
DO46493
0 years, female, NA, stage:IV, alive, 839 days
1021.2
DO46392
0 years, female, NA, stage:III, dead, 628 days
1000.7
DO46325
0 years, female, NA, stage:III, dead, 477 days
993.8
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
984.1
DO46551
0 years, female, NA, stage:III, dead, 1055 days
979.5
DO46376
0 years, female, NA, stage:III, dead, 1430 days
969.9
DO46352
0 years, female, NA, stage:III, dead, 677 days
961.7
DO46518
0 years, female, NA, stage:III, alive, 2960 days
929.0
DO46586
0 years, female, NA, stage:III, dead, 1019 days
908.5
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
902.4
DO46404
0 years, female, NA, stage:III, dead, 690 days
896.5
DO46372
0 years, female, NA, stage:III, dead, 1326 days
893.7
DO46538
0 years, female, NA, stage:III, dead, 1527 days
891.6
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
890.4
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
885.4
DO46368
0 years, female, NA, stage:III, dead, 2879 days
839.9
DO46334
0 years, female, NA, stage:III, dead, 496 days
835.9
DO46468
0 years, female, NA, stage:III, alive, 2776 days
833.8
DO46378
0 years, female, NA, stage:III, alive, 843 days
810.7
DO46338
0 years, female, NA, stage:III, dead, 596 days
805.5
DO46400
0 years, female, NA, stage:III, dead, 719 days
773.5
DO46597
0 years, female, NA, stage:III, dead, 393 days
773.3
DO46528
0 years, female, NA, stage:III, alive, 6139 days
725.1
DO46328
0 years, female, NA, stage:III, dead, 972 days
714.9
DO46581
0 years, female, NA, stage:III, dead, 408 days
713.0
DO46358
0 years, female, NA, stage:III, dead, 423 days
695.1
DO46330
0 years, female, NA, stage:III, dead, 684 days
689.8
DO46463
0 years, female, NA, stage:III, dead, 2451 days
684.0
DO46354
0 years, female, NA, stage:III, dead, 843 days
682.6
DO46362
0 years, female, NA, stage:III, dead, 1639 days
668.6
DO46448
0 years, female, NA, stage:III, dead, 654 days
667.6
DO46398
0 years, female, NA, stage:III, alive, 437 days
667.0
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
661.0
DO46327
0 years, female, NA, stage:III, dead, 184 days
656.3
DO46386
0 years, female, NA, stage:III, dead, 1162 days
629.1
DO46606
0 years, female, NA, stage:III, alive, 804 days
611.5
DO46329
0 years, female, NA, stage:III, dead, 1699 days
594.9
DO46508
0 years, female, NA, stage:III, dead, 2101 days
578.4
DO46436
0 years, female, NA, stage:III, alive, 3193 days
567.8
DO46533
0 years, female, NA, stage:III, alive, 3667 days
562.3
DO46374
0 years, female, NA, stage:III, dead, 1409 days
556.6
DO46561
0 years, female, NA, stage:III, dead, 195 days
536.2
DO46560
0 years, female, NA, stage:IV, dead, 286 days
533.8
DO46388
0 years, female, NA, stage:III, dead, 413 days
532.5
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
528.2
DO46344
0 years, female, NA, stage:III, dead, 642 days
522.7
DO46571
0 years, female, NA, stage:III, dead, 243 days
495.9
DO46588
0 years, female, NA, stage:III, dead, 438 days
489.5
DO46408
0 years, female, NA, stage:III, dead, 489 days
483.9
DO46346
0 years, female, NA, stage:III, dead, 1187 days
472.9
DO46566
0 years, female, NA, stage:III, dead, 673 days
449.9
DO46336
0 years, female, NA, stage:IV, dead, 664 days
420.9
DO46382
0 years, female, NA, stage:IV, dead, 311 days
401.6
DO46348
0 years, female, NA, stage:IV, dead, 287 days
400.6
DO46396
0 years, female, NA, stage:III, dead, 583 days
374.9
DO46332
0 years, female, NA, stage:III, dead, 689 days
371.4
DO46340
0 years, female, NA, stage:III, dead, 616 days
366.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.3
15524912-685a-47ce-a824-567848_D2
Tumor
1.0
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.9
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.8
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.7
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.6
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.6
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.6
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.5
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.5
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.4
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.4
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.4
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.4
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.4
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.4
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.3
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.3
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.3
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.2
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.2
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.2
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.1
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.1
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.1
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.1
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.0
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.0
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.0
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.0
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.0
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.0
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.0
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.1
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.1
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.1
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-0.1
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.1
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-0.1
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.1
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.2
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.2
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.2
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.2
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.2
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-0.2
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.2
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.2
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.3
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.3
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.3
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.3
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.3
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.3
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.3
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.4
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.4
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.4
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.4
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.4
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.4
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.4
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.4
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.4
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.4
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.4
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.4
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.4
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.4
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.4
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.5
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.5
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.5
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.5
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.6
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.6
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.6
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.6
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.7
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.7
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.7
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.8
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.8
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.9
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.9
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-1.0
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.